XORTX Therapeutics Inc
Change company Symbol lookup
Select an option...
XRTX XORTX Therapeutics Inc
RFL Rafael Holdings Inc
PLL Piedmont Lithium Inc
PPIH Perma-Pipe International Holdings Inc
PANL Pangaea Logistics Solutions Ltd
JAN Janone Inc
IMCC IM Cannabis Corp
FSNB Fusion Acquisition Corp II
SCPL Sciplay Corp
MKNGF Mkango Resources Ltd
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

XORTX Therapeutics Inc. is a pharmaceutical company. The Company is focused on identifying, developing and commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan (rare) disease indications, such as autosomal dominant polycystic kidney disease (ADPKD) and type 2 diabetic nephropathy (T2DN) as well as acute kidney injury (AKI) associated with coronavirus infection. Its three lead product candidates are XRx-008, for the treatment of ADPKD; XRx-101, to treat AKI associated with Coronavirus / COVID-19 infection, AKI and associated health consequences. In addition, XRx-225 is a pre-clinical stage program for type 2 diabetic nephropathy. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company is evaluating xanthine oxidase inhibitor candidates for the XRx-225 program to treat T2DN.

Closing Price
$0.6143
Day's Change
-0.0777 (-11.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.67
Day's Low
0.5705
Volume
(Light)
Volume:
929,754

10-day average volume:
4,553,813
929,754
  • Prev Close
    0.692
  • Today's Open
    0.58
  • Day's Range
    0.5705-0.67
  • Avg Vol (10-day)
    4.6M
  • Last (time)
    4:00p ET 01/27/23
  • Last (size)
    145
  • 52-Wk Range
    0.5705 - 2.48
    LowHigh
  • (03/23/22 - 01/27/23)
    7.68%
  • 124.1%
  • Market Cap
    8.8M
  • Shares Outstanding
    14.4M
  • 0.23
  • 3.57x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.2
  • 6.83
  • (% of float 01/15/23)
    1.10

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.